Benzinga Research

Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise

Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto

Free Benzinga Pro Trial

Calendars

Analyst Ratings Calendar

Conference Call Calendar

Dividend Calendar

Earnings Calendar

Economic Calendar

Guidance Calendar

Stock Split Calendar

Trade Ideas

Free Stock Reports

Trade Idea Feed

Analyst Ratings

Unusual Options Activity

Free Newsletter

Government Trades

Perfect Stock Portfolio

Easy Income Portfolio

Short Interest

Largest Increase

Largest Decrease

Calculators

Margin Calculator

Forex Profit Calculator

100x Options Profit Calculator

Comments

Loading...

Revitalist Lifestyle Stock News

RVLWFOTCEM

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

Perks Buy Compare Brokers

Revitalist Lifestyle (RVLWF) Forecast

News

Earnings Revitalist Lifestyle (RVLWF) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Latest Revitalist Lifestyle Stock News | OTC:RVLWF | Benzinga

Get the latest news on Revitalist Lifestyle stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on Revitalist Lifestyle performance

Categories: All

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

Monday, April 17, 2023

Psyched: Clinical-Grade MDMA, LSD For Depression, Partnerships For Delivering Psychedelic Therapies & More
Lara Goldstein

Friday, April 14, 2023

EXCLUSIVE: Ketamine Therapy Leaders Share Bold Vision For Future At Benzinga's Psychedelics Capital Conference
Lara Goldstein

Wednesday, April 12, 2023

Are You One Of The Lucky 50,000? New Pact Opens Psychedelic Treatment Floodgates
Lara Goldstein

Monday, January 30, 2023

Women's Footprint In Psychedelics Is Undeniable, Benzinga's Psychedelics Advisory Council's Six New Trailblazers
Lara Goldstein

Tuesday, November 22, 2022

Psyched: Musk's Empathy Tweets, Psychedelics In Congress, Oregon's Opt-Outs, MAPS' MDMA Trial And More
Lara Goldstein

Tuesday, November 15, 2022

New Collaboration Will Bring Psychedelic Clinics & Retreats With Vertical Offerings To The U.S.
Lara Goldstein

Friday, November 04, 2022

Psychedelics Company Launches New Supplements Line, Joins Global Wellness Market
Lara Goldstein

Tuesday, November 01, 2022

Ketamine Therapy: Revitalist's New Financing Option, Irwin Naturals Expands Chain Of Clinics
Lara Goldstein

Friday, October 28, 2022

What Are The Best Psychedelic-Assisted Therapy Clinics In The World? Here Are 5 To Check Out
Lara Goldstein

Monday, October 03, 2022

Justice Dept Grants $1M To Non-Profits To Help Stem Teen Mental Health Issues & School Violence
Lara Goldstein

Wednesday, September 14, 2022

Psychedelics Companies Are Teaming Up To Offer Access Veterans
Lara Goldstein

Friday, August 19, 2022

There Could Be More Hope For Alcohol Addicts As This Company Enters U.S. Addiction Treatment And Relapse Prevention Market
Ernest Dela Aglanu - Sponsored

Tuesday, August 16, 2022

Awakn Enters U.S. Addiction Treatment & Relapse Prevention Market With Ketamine Therapy For Alcohol Use Disorder
Lara Goldstein

Tuesday, June 28, 2022

10 Psychedelics CEOs To Pay Attention To In 2022
Javier Hasse

Thursday, June 16, 2022

Ketamine-Clinics Revitalist Raises Nearly $4M In Second Round Of Private Placement
Lara Goldstein

Popular Channels

PreMarket Playbook
Press Releases
Analyst Ratings
News
Options
ETFs

Tools & Features

Real Time Feed
Public RSS Feeds
Submit News Tips
Blog
Embeddable Finance Widgets & Tools
Benzinga Catalyst

Partners & Contributors

Affiliate Program
Contributor Portal
Licensing & Syndication
Sponsored Content
Advertise With Us
Lead Generation & SEO

About Benzinga

About Us
Careers
In The News
Events
Contact Us

Terms & Conditions
Do Not Sell My Personal Data/Privacy Policy
Disclaimer
Service Status
Sitemap

© 2025 Benzinga | All Rights Reserved